Aandeel ACUT ACCUSTEM SCIENCES, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen AccuStem Sciences, Inc.

Aandelen

ACUT

US00444A1016

Beurs gesloten - OTC Markets
Andere beurzen
 17:37:08 27-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,41 USD -3,95% Intraday-grafiek van AccuStem Sciences, Inc. +4,83% -34,47%
20/05 AccuStem Sciences, Inc. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 CI
22/03 AccuStem Sciences, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
AccuStem Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
AccuStem Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
AccuStem Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
Accustem Sciences, Inc. and Emeritusdx Announce Joint Product Development Agreement and Strategic Partnership
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers (form 8-K)
Accustem Sciences Inc. Announces Resignation of Jeff Fensterer as Chief Operating Officer, Effective as of June 16, 2023
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
AccuStem Announce Strategic Clinical and Operational Partnership
Accustem Sciences Inc. Announces Strategic Clinical and Operational Partnership
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer
ACCUSTEM SCIENCES INC. : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
ACCUSTEM SCIENCES INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers ACUT
  4. Nieuws AccuStem Sciences, Inc.
  5. Andere talen